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Summary
 
Lipopolysaccharide (LPS) stimulates immune responses by interacting with the membrane
receptor CD14 to induce the generation of cytokines such as tumor necrosis factor (TNF)-
 
a
 
,
interleukin (IL)-1, and IL-6. The mechanism by which the LPS signal is transduced from the
extracellular environment to the nuclear compartment is not well defined. Recently, an in-
creasing amount of evidence suggests that protein tyrosine kinases especially the Src-family ki-
nases Hck, Fgr, and Lyn, play important roles in LPS signaling. To directly address the physio-
logical function of Hck, Fgr and Lyn in LPS signaling, a genetic approach has been used to
generate null mutations of all three kinases in a single mouse strain.
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 mice are
moderately healthy and fertile; macrophages cultured from these mice express normal levels of
CD14 and no other Src-family kinases were detected. Although the total protein phosphoty-
rosine level is greatly reduced in macrophages derived from 
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mice, functional
analyses indicate that both elicited peritoneal (PEMs) and bone marrow–derived macrophages
(BMDMs) from triple mutant mice have no major defects in LPS-induced activation. Nitrite
production and cytokine secretion (IL-1, IL-6, and TNF-
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) are normal or even enhanced in
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 macrophages after LPS stimulation. The development of tumor cell cytotox-
icity is normal in triple mutant BMDMs and only partially impaired in PEMs after LPS stimu-
lation. Furthermore, the activation of the ERK1/2 and JNK kinases, as well as the transcription
factor NF-
 
k
 
B, are the same in normal and mutant macrophages after LPS stimulation. The cur-
rent study provides direct evidence that three Src-family kinases Hck, Fgr, and Lyn are not
obligatory for LPS-initiated signal transduction.
 
L
 
ipopolysaccharide (LPS)
 
1
 
, an outer membrane compo-
nent of Gram negative bacteria, is a potent activator of
monocytes and macrophages. LPS triggers the abundant se-
cretion of many cytokines from macrophages including IL-1
(1), IL-6 (2), and TNF-
 
a
 
 (3),
 
 which together contributes
to the pathophysiology of septic shock. The major cell sur-
face receptor for LPS on macrophages is CD14, a 55-kD
glycosyl-phosphatidylinositol–linked membrane protein (4).
High-affinity binding of LPS to CD14 is greatly enhanced
by the presence of the serum protein LPS-binding protein
(5). The crucial role played by CD14 in initiating LPS re-
sponses has been demonstrated in animal models. Trans-
genic mice overexpressing CD14 are hypersensitive to LPS
(6), while CD14-deficient mice show no responses to low-
dose LPS stimulation (7). At higher concentrations of LPS,
macrophages may be activated by a CD14-independent
pathway since anti-CD14 mAbs do not block all biological
responses (8, 9).
Comparatively less is known about intracellular signaling
events after binding of LPS to CD14 (10). There is evi-
dence to suggest that G proteins (11), phospholipase C
(12), protein kinase A, and protein kinase C (13) are in-
volved in LPS responsiveness. Strong evidence indicates
that protein tyrosine kinases (PTKs) play critical roles in
LPS signaling. Within minutes of LPS stimulation, numer-
ous proteins become tyrosine phosphorylated, in particular
MAP kinases p42 (ERK2), p44 (ERK1), and p38, the mam-
malian homologue of the yeast MAPK-like kinase HOG1
(14–17). Synchronous with tyrosine phosphorylation these
MAPKs also become enzymatically activated. The c-Jun
kinase (JNK) also becomes enzymatically activated within
minutes after LPS treatment of macrophages (15). Direct
stimulation of the ceramide-activated protein kinase by
LPS has also been suggested as a major signaling mechanism
(18). Pretreatment of cells with herbimycin A, a general
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LPS Signaling in 
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protein tyrosine kinase inhibitor, blocks phosphorylation of
the MAPKs and inhibits LPS-induced biological responses
(16, 17). More specific tyrosine kinase inhibitors of the tyr-
phostin family also block LPS-induced TNF-
 
a
 
 production
and MAPK phosphorylation, and prevent septic shock in
mice (19).
Three members of the Src-family of protein tyrosine ki-
nases, Hck, Fgr, and Lyn are strong candidates for the pri-
mary signal transducers of LPS responses (20–25). All three
of these kinases are rapidly activated after LPS treatment.
A portion of intracellular Lyn directly co-associates with
CD14 (21). LPS-induced association of Lyn with PI 3-kinase
has also been observed (23). Moreover, expression in mac-
rophages of a constitutively active mutant of Hck augments
TNF-
 
a
 
 production while antisense oligonucleotides to Hck
inhibit LPS-induced responses (26). Chronic exposure (24–
48 h) of macrophages to LPS induces increased synthesis of
Hck and Lyn, which correlates with the ability of LPS to
prime macrophages for respiratory burst (22). All of these
observations suggest that protein tyrosine kinases, especially
Hck, Fgr, and Lyn play critical roles in LPS-initiated signal-
ing pathways.
To directly test the role of the Src-family kinases, Hck,
Fgr, and Lyn in LPS signal transduction, we used macrophages
from triple knockout mice that were generated by inter-cross-
ing 
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 animals. Since these three kinases
are the primary Src-family kinases expressed in macrophages
(27), cells from 
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 triple mutant mice have
little, if any, Src-family kinase activity. Resting bone marrow
macrophages and inflammatory thioglycolate-elicited peri-
toneal macrophages were used in this study. Surprisingly, LPS-
induced cytokine secretion, nitrite production, and tumor-
icidal activity were all essentially normal in triple knockout
macrophages. Although overall tyrosine phosphorylation
was dramatically reduced in these cells, phosphorylation of
MAPKs occurred normally after LPS stimulation. These stud-
ies convincingly demonstrate that the major Src-family kinases
present in macrophages, Hck, Fgr, and Lyn are not obliga-
tory in LPS-mediated signal transduction.
 
Materials and Methods
 
Generation of hck
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double mutant
mice and 
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 single mutant mice were generated as previously
described (Chan, V., F. Meng, A. DeFranco, and C. Lowell, manu-
script submitted for publication and reference 28).
 
hck
 
2
 
/
 
2
 
fgr
 
2
 
/
 
2
 
 
 
double mutant and 
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 single mutant were in-
terbred to generate 
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triple deficient mice. Genotyp-
ing of offspring was performed by PCR using specific primers and
further confirmed by immunoblotting using specific polyclonal
antibodies against Hck, Fgr, and Lyn. Primer sequences used to
specifically amplify the wild-type 
 
hck 
 
gene were:
 
 hck 
 
forward 5
 
9
 
GCT CCA TAG ATC CGT CGT GCC ATT TCC 3
 
9
 
 and 
 
hck
 
reverse 5
 
9
 
 GTT GTT TGG TCC CAG CTT GCT GGA GG 3
 
9
 
.
To amplify the 
 
hck
 
 mutant allele, primers, 
 
hck
 
 forward and 3
 
9
 
 neo,
5
 
9
 
 GCA TCG CCT TCT ATC GCC TTC TTG ACG 3
 
9
 
, were
used. To specifically amplify the 
 
fgr
 
 wild-type allele, primers,
 
 fgr
 
forward, 5
 
9
 
 CAA GGC CGG ACT TCG TCC GTC TTT CC
3
 
9
 
, and 
 
fgr 
 
reverse, 5
 
9
 
 GAG AGC CTT ACT GGA ATC CCT
CTT TAG C 3
 
9
 
 were used. The 
 
fgr
 
 mutant allele was detected
using primers, 5
 
9
 
 neo, 5
 
9
 
 CAG TCA TAG CCG AAT AGC
CTC TCC ACC 3
 
9
 
, and 
 
fgr
 
 reverse. The 
 
lyn 
 
wild-type allele was
amplified with 
 
lyn
 
 forward-2, 5
 
9
 
 CAT AGC CTG AGT TAG
TTC CCT AGC 3
 
9
 
, and 
 
lyn
 
 reverse, 5
 
9
 
 TCA CAT ATG AAC
ATG TGT GTG TAC ATG TC 3
 
9
 
. These primers amplify only
the active 
 
lyn 
 
wild-type gene and do not react with the pseudo-
gene (Chan et al., manuscript submitted for publication). The
mutant 
 
lyn
 
 gene was amplified with the 3
 
9
 
 neo and 
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 6.2. 5
 
9
 
AGC CAC CAT TGT CCA GAC TTC 3
 
9
 
. PCR reactions
were carried out in a 20-
 
m
 
l vol containing 1
 
3
 
 PCR buffer (Per-
kin-Elmer Cetus Instrs., Norwalk, CT), 200 
 
m
 
M dNTPs, 10%
DMSO, 1
 
3
 
 readiload (Research Genetics, Huntsville, AL), 0.4
 
m
 
M primers, 2 U Taq DNA polymerase, and 
 
z
 
100 ng tail biopsy
DNA. Reaction conditions were: 94
 
8
 
C 45
 
99
 
, 60
 
8C 4599, 748C
6099 for 35 cycles. The lyn PCR was done at 948C 4599, 558C
4599, 748C 6099. PCR products were resolved on a 2% agarose
gel (1% regular, 1% Nu-Sieve GTG agarose; FMC Corp., Rock-
land, ME).
Isolation and Culture of Macrophages. PEMs and BMDMs were
obtained as described by Lowell et al. (28). BMDMs were cul-
tured in a 378C incubator with 5% CO2 in a-MEM (GIBCO
BRL, Gaithersburg, MD) containing 20% L cell conditioned me-
dium and 10% fetal calf serum for 7 d before use. PEMs were cul-
tured in DMEM containing 10% fetal calf serum for 2 h and non-
adherent cells were washed away before use. Macrophages were
stimulated with IFN-g (20 ng/ml) and different concentrations of
LPS for indicated times.
Preparation of Cell Lysates and Immunoblotting. After stimulation
with LPS, PEMs and BMDMs were washed once with cold 13
PBS, then lysed in lysis buffer (150 mM NaCl, 10 mM Tris, pH
7.0, 10 mM EDTA, 1% Triton X-100, 0.5% deoxycholate, 1 mM
Na2VO4, 1 mM PMSF, and 1 mg/ml each of leupeptin/pepsta-
tin/aprotinin). The protein concentrations were determined us-
ing the Bio-Rad protein assay (Bio-Rad Labs., Richmond, CA).
Total protein extracts (30 mg) were electrophoresed on 10%
SDS-PAGE and transferred to nitrocellulose membranes. For im-
munoblotting with mAbs, antiphosphotyrosine mAb 4G10 (UBI,
Lake Placid, NY), anti-Src mAb 327 (UBI), and anti-Yes mAb
(gift from M. Sudol, Mount Sinai School of Medicine, NY), the
nitrocellulose membrane was blocked with 2% BSA in TBST
(150 mM NaCl, 25 mM Tris, pH 7.5, 0.2% Tween-20) for 1 h at
room temperature. For immunoblotting with rabbit polyclonal
antibodies, anti-Lck, anti-Fyn (both from Santa Cruz, Biotech-
nology, Santa Cruz, CA), anti-Hck, anti-Fgr, anti-Lyn, and anti-
Blk (produced against the unique domain of each protein; refer-
ences 28, 29), the nitrocellulose membrane was blocked with 5%
milk/10% goat serum in TBST for 1 h at room temperature.
Membranes were incubated sequentially with primary antibodies
followed by peroxidase-conjugated secondary antibodies for 1 h
at room temperature with continuous shaking. Specific binding
was visualized by the enhanced chemiluminescent detection sys-
tem (ECL; Amersham Corp., Arlington Heights, IL).
Nitrite Assay. PEMs and BMDMs were seeded on 96-well
plates at 1 3 105 cells per well and cultured in 120 ml of appropri-
ate media in the presence or absence of LPS and IFN-g for 12 h.
NO2
2 released into supernatants was measured with Greiss re-
agent as described (30).
Quantitation of Cytokines and Herbimycin A Treatment. The levels
of IL-1 and TNF-a in the supernatants were determined by
ELISA kits (IL-1; R&D Systems, Minneapolis, MN and TNF-a;
Genzyme Corp., Cambridge, MA) using protocols described by
the manufacturers. IL-6 was measured by ELISA using specific1663 Meng and Lowell
antibody pairs (PharMingen, San Diego, CA). In brief, 96-well
plates were coated with 4 mg/ml purified rat anti–mouse IL-6
overnight at 48C and blocked with PBS/10% fetal calf serum for
1 h at room temperature. 50 ml of cell culture supernatants, which
were harvested from cells stimulated by LPS and IFN-g for 12 h,
were added to each well and incubated at room temperature for 2 h.
After washing with PBS/0.2% Tween-20, biotin-conjugated rat
anti–mouse IL-6 was added and incubated for 45 min. Wells
were washed and then incubated with avidin-peroxidase for 30
min. After washing, ABTS substrate (Zymed Labs., South San
Francisco, CA) diluted in 0.1 M citric acid buffer (pH 4.0) was
added to each well and incubated for 30 min. The optical density
at 405 nm was measured with a microtiter plate reader (Molecular
Devices Corp., Menlo Park, CA). For herbimycin A treatment,
adherent PEMs were treated with 10 mg/ml herbimycin A (Sigma
Chem. Co., St. Louis, MO) for 4 h before stimulating with LPS
and IFN-g.
Cytotoxicity Assay. Different numbers of PEMs and BMDMs
were seeded on 96-flat well plates and stimulated with LPS (100
ng/ml) and IFN-g (20 ng/ml) for 48 h. 104 P815 tumor cells
prelabeled by incubation with 10 mCi of [3H]thymidine for 12 h
were overlaid on the activated macrophages. After co-culture of
tumor cells and stimulated macrophages for 24 h, 100 ml superna-
tant was used to determine [3H]thymidine release by liquid scin-
tillation counting. The specific release was calculated based on the
formula described by Jadus et al. (31).
ERK and JNK Kinase Assay. PEMs and BMDMs that were
prestimulated with LPS (10 ng/ml) and IFN-g (20 ng/ml) were
lysed in lysis buffer. Total protein lysates prepared from LPS/
IFN-g–stimulated PEMs or BMDMs were immunoprecipitated
(250 mg/assay) with ERK1/2 (antibody cross-reacts with both
ERK isoforms) and JNK specific polyclonal antibodies, respec-
tively (Santa Cruz Biotechnology), for 1 h at 48C and incubated
with 2% BSA preblocked protein A–Sepharose beads for another
hour at 48C with continuous shaking. After washing twice in lysis
buffer and once in kinase buffer (20 mM Hepes, pH 7.0, 10 mM
MgCl2, 0.5% Triton X-100, 10 mM MnCl2, and 0.1 mM
Na2VO4), 10 mCi g-[33P]ATP and 25 mg of the exogenous sub-
strates myelin basic protein (Sigma) and c-Jun fusion protein (gift
of J. Hambleton, University of California, San Francisco, CA) were
added to the immunocomplexes of ERK1/2 and JNK, respectively,
and incubated for 15 min at 308C. The protein samples were
boiled in 23 Laemmli buffer for 5 min and separated by 12%
SDS-PAGE followed by autoradiography.
NF-kB Assay. PEMs and BMDMs (5 3 106) were seeded
onto 100-mm plates and stimulated with IFN-g (20 ng/ml) and
LPS (10 ng/ml) for 2 h. Preparation of nuclear extracts was per-
formed as described by Kitchens et al. (32). Sense and antisense
oligonucleotides, containing the NF-kB recognition sequences
derived from the murine immunoglobulin k enhancer, were syn-
thesized, annealed and labeled with a-[32P]dCTP using Klenow
fragment as described by Hambleton et al. (15). To assess for non-
specific binding, a double-stranded oligonucleotide containing a
point mutation in the NF-kB–binding site that was incapable of
binding NF-kB, was also prepared. Labeled oligonucleotides
were incubated with nuclear extracts for 15 min, then NF-kB–bound
oligonucleotides were resolved on a 4% TBE gel.
Results
Generation of hck2/2fgr2/2lyn2/2 Mice. To generate the hck2/2
fgr2/2lyn2/2–deficient mice, hck2/2fgr2/2 double mutant mice
and lyn2/2 single mutant mice were crossed. Genotyping of
offspring was performed by PCR as shown in Fig. 1 A.
Mice from this cross were interbred for several generations
until triple mutant animals were obtained. The hck2/2fgr2/2
lyn2/2  mice are fertile and have no general physiologic
phenotypes beyond that seen for the lyn2/2 single mutant
mice (Chan et al., manuscript submitted for publication
and references 33, 34, 35). All single mutant animals used
to generate the triple knockout line had been back-crossed
at least two generations to C57BL/6 mice. To verify each
gene disruption in the triple mutants, proteins correspond-
ing to Hck, Fgr, and Lyn were examined using specific
polyclonal antibodies. Expression of Hck, Fgr, and Lyn was
only detected in wild-type macrophages but not in hck2/2
fgr2/2lyn2/2 homozygotes (Fig. 1 B). FACSÒ analysis of res-
ident peritoneal macrophages, PEMs and BMDMs from
hck2/2fgr2/2lyn2/2 animals showed normal expression levels
of CD14, Mac-1, Mac-2, F4/80, MHC class I, and CD29
(b1 integrin) surface molecules (data not shown).
Other Src-family Kinases Are Not Upregulated in Macrophages
Derived from hck2/2fgr2/2lyn2/2Mice. To address the possibil-
ity that other Src-family kinases might be upregulated or
aberrantly expressed in macrophages derived from hck2/2fgr2/2
lyn2/2 mice, we examined the expression level of all other
Src-family members in these cells by immunoblotting. The
expression level of other Src-family kinases was examined
using a panel of mAbs or polyclonal Abs specific for each
family member. As shown in Fig. 2, no other Src-family
kinases were detectable in hck2/2fgr2/2lyn2/2 macrophages
although each protein was easily seen in extracts prepared
from brain tissue or lymphocytes. We conclude that hck2/2
fgr2/2lyn2/2 macrophages have no significant expression of
any Src-family kinases.
Production of Nitrite and Cytokines in hck2/2fgr2/2lyn2/2
Mice upon Stimulation with LPS and IFN-g. Since there is
extreme heterogeneity of macrophages (36) and their re-
sponses to LPS, we performed all our experiments on both
Figure 1. Genotype of offspring from heterozygous parents. (A) Ge-
nomic DNA was isolated from tail biopsies and analyzed by PCR. PCR
primers were designed such that amplification of a larger fragment oc-
curred from the mutant allele of all three genes while the smaller fragment
indicates the wild-type allele. PCR was performed as described in Materi-
als and Methods. DNA from wild-type (1/1), triple heterozygous (1/2),
and triple homozygous (2/2) mice is shown. (B) hck2/2fgr2/2lyn2/2 mice
do not express Hck, Fgr, and Lyn proteins. Total cellular lysates were pre-
pared from BMDMs of wild-type (1/1) or triple mutant (2/2) animals
and examined for Hck, Fgr, and Lyn by immunoblotting as described in
Materials and Methods. Hck, Fgr, and Lyn were also not detected in
PEMs from triple mutant mice (data not shown).1664 LPS Signaling in hck2/2fgr2/2lyn2/2 Mice
inflammatory PEMs and BMDMs. To investigate the im-
portance of Hck, Fgr, and Lyn in LPS-induced macrophage
activation, we evaluated the LPS concentration-dependent
induction of nitrite, IL-1, IL-6, and TNF-a in both wild-
type and mutant cells. Over a wide range of LPS concen-
trations, there was no impairment of nitrite production in
hck2/2fgr2/2lyn2/2 macrophages compared to wild-type cells
(Fig. 3). BMDMs from wild-type and triple mutant mice
produced equivalent amounts of nitrite in response to LPS
stimulation alone; PEMs did not respond to LPS-alone
stimulation. To further prime macrophages for LPS re-
sponses, we stimulated cells with the combination of LPS
and IFN-g. With this costimulation, BMDMs produced
more nitrite and manifested a left-shift in the LPS dose re-
sponse curve; again, both wild-type and mutant macrophages
responded equivalently. LPS/IFN-g costimulation of PEMs
induced abundant nitrite production in wild-type mac-
rophages while triple mutant PEMs appeared hyperrespon-
sive, especially at low doses of LPS (0.001–0.01 ng/ml),
compared to wild-type mice. In the absence of LPS, IFN-g
alone failed to induce nitrite release from both PEMs and
BMDMs.
Similarly, both types of triple mutant macrophages pro-
duced abundant amounts of IL-1, IL-6, and TNF-a at 12 h
after LPS stimulation (Fig. 4). As seen with nitrite produc-
tion, cytokine release from PEMs only occurred with LPS/
IFN-g costimulation, while BMDMs showed a left-shift of
Figure 2. Expression of Src-family kinases in hck2/2fgr2/2lyn2/2 mac-
rophages. Total protein extracts (30 mg) obtained from BMDMs of wild-
type (W) or triple mutant (T) mice were electrophoresed on 10% SDS-
PAGE and transferred to nitrocellulose as described in Materials and
Methods. Membranes were blotted with different antibodies against Src-
family kinases. Brain (B) and lymphocyte (L) extracts used as positive con-
trols for antibody binding. Similar to these results, expression of other
Src-family kinases was not observed in triple mutant PEMs (data not
shown).
Figure 3. Nitrite secretion in response to LPS or LPS 1 IFN-g stimu-
lation. PEMs or BMDMs from wild-type or triple mutant mice were cul-
tured in 96-well plates (105 cells/well) in the presence of LPS, at the indi-
cated concentrations, with or without addition of IFN-g (20 ng/ml).
NO2
2 release was determined with the Greiss reagent after 24 h of cul-
ture. Triplicate samples at each LPS concentration were averaged and
plotted 6 SD. Results shown are averaged data from three independent
experiments. WT (triangles); WT 1 IFN-g (squares); hck2/2fgr2/2lyn2/2
(circles); hck2/2fgr2/2lyn2/21 IFN-g (diamonds).
Figure 4. Secretion of IL-1, IL-6, and TNF-a in response to LPS and
IFN-g stimulation. PEMs or BMDMs from either wild-type or triple
mutant mice were cultured in 96-well dishes (5 3 105 cells/well) and
stimulated with LPS and IFN-g (20 ng/ml) for 12 h. The concentration
of IL-1, IL-6, and TNF-a in the culture media was determined by
ELISA. Determinations were performed on triplicate samples and plotted 6
SD. Results shown are averaged data from three independent experi-
ments. WT 1 IFN-g (squares); hck2/2fgr2/2lyn2/21 IFN-g (diamonds).1665 Meng and Lowell
the LPS dose-response curve with the addition of IFN-g
(data not shown). hck2/2fgr2/2lyn2/2 PEMs demonstrated
dramatically increased production of IL-1 compared to wild-
type PEMs; triple mutant BMDMs also showed slightly in-
creased IL-1 production compared to wild-type cells. The
wild-type PEMs and BMDMs produced nearly the same
amount of IL-1 after LPS/IFN-g stimulation; note the
change in scale between PEMs and BMDMs. Triple mu-
tant PEMs also showed increased IL-6 production com-
pared to wild-type cells; responses of BMDMs were equiv-
alent. There were no differences in TNF-a production
between triple mutant and wild-type PEMs or BMDMs.
These data strongly support the conclusion that macrophages
lacking Hck, Fgr, and Lyn can be readily activated by LPS.
Indeed, PEMs from the triple mutant mice showed en-
hanced responses to LPS/IFN-g stimulation compared to
wild-type cells.
Partially Impaired Tumor Cytotoxicity in PEMs Derived from
hck2/2fgr2/2lyn2/2–deficient Mice. Another major functional
response of LPS-stimulated macrophages is the develop-
ment of tumoricidal activity. To test the tumoricidal ability
of macrophages derived from the hck2/2fgr2/2lyn2/2 mice,
we assessed cytotoxicity against P815 mastocytoma cells af-
ter stimulation with LPS and IFN-g. As demonstrated in
Fig. 5, the stimulated macrophages killed tumor cells in a
fashion proportional to the macrophage/tumor cell ratio;
greater killing was seen at higher macrophage cell numbers
in both wild-type and triple mutant mice. The extent of
killing by PEMs derived from hck2/2fgr2/2lyn2/2 mice was
reproducibly less than wild-type PEMs at higher macrophage/
tumor cell ratios. This was not observed in BMDMs. This
evidence demonstrates that tumoricidal activity could be
induced in hck2/2fgr2/2lyn2/2 macrophages by stimulation
with LPS and IFN-g.
hck2/2fgr2/2lyn2/2 Macrophages Have Reduced Overall Ty-
rosine Phosphotyrosine Levels but Normal MAPK Phosphophor-
ylation after LPS Stimulation. To test the effects of loss of
Hck, Fgr, and Lyn on the overall level of protein tyrosine
phosphorylation, we assessed changes in tyrosine phosphor-
ylation after LPS/IFN-g stimulation, in both PEMs and
BMDMs, using antiphosphotyrosine immunoblotting. As
shown in Fig. 6, we observed that hck2/2fgr2/2lyn2/2 mac-
rophages showed dramatically decreased tyrosine phosphor-
ylation of multiple proteins in both resting and LPS-stimu-
lated cells. One protein with an apparent molecular mass of
z42 kD was rapidly tyrosine phosphorylated upon LPS/
IFN-g stimulation in both wild-type and triple mutant
PEMs and BMDMs. This protein was one or both of the
p42/p44 (ERK2/ ERK1) MAP kinase isoforms (confirmed
by re-probing this blot with anti-ERK1/2, data not shown),
as has been demonstrated previously (16, 17). Interestingly,
hck2/2fgr2/2lyn2/2 PEMs show slightly higher and more sus-
tained tyrosine phosphorylation of the MAPKs compared
to wild-type PEMs. In BMDMs, there was no difference in
p42 phosphorylation between wild-type and triple mutant
macrophages. p42 phosphorylation in PEMs was detectable
after 15 min after LPS stimulation, reached a maximum by
60 min, and declined at 120 min.
Analysis of ERK1/2 and JNK Activity in LPS-Treated Mac-
rophages. To evaluate the role of Hck, Fgr, and Lyn in
LPS-induced activation of MAPKs, we determined ERK1/2
Figure 5. Analysis of tumor cytotoxicity. Different numbers of PEMs
and BMDMs derived from wild-type and hck2/2fgr2/2lyn2/2 mutant mice
were plated on 96-well plates and activated with LPS (10 ng/ml) and
IFN-g (20 ng/ml) for 48 h and then overlaid with 104 [3H]thymidine-
labeled P815 tumor cells. Cytotoxic activity against p815 cells was as-
sessed by [3H]thymidine released into the culture supernatant after 24 h of
coculture. Data is presented as % specific release 6 SD of triplicate sam-
ples (100% was defined as the amount of [3H]thymidine in cells lysed with
detergents). Specific release in the absence of LPS/IFN-g stimulation is
shown as NS. Experiment is representative of three independent experi-
ments. Wild type (open bars); hck2/2fgr2/2lyn2/2 (shaded bars).
Figure 6. Protein-tyrosine phosphorylation after LPS/IFN-g stimula-
tion. PEMs and BMDMs from wild-type and hck2/2fgr2/2lyn2/2 mice
were stimulated with LPS (10 ng/ml) and IFN-g (20 ng/ml) for the dif-
ferent time points indicated. Total cell lysates were prepared and separated
on 10% SDS-PAGE and transferred to nitrocellulose as described in Ma-
terials and Methods. Filters were blotted with antiphosphotyrosine with
4G10, followed by peroxidase-conjugated secondary antibody and
chemiluminescent detection.1666 LPS Signaling in hck2/2fgr2/2lyn2/2 Mice
and JNK kinase activity using defined substrates. ERK1/2
kinase activity was determined by phosphorylation of MBP.
In both PEMs and BMDMs, ERK1/2 kinase activity was
activated after LPS/IFN-g treatment in hck2/2fgr2/2lyn2/2
cells compared to wild-type cells (Fig. 7). No consistent
difference in ERK1/2 activation was observed between
wild-type and mutant cells. The activation of ERK1/2 was
detected at 60 min and declined at 2 h after LPS and IFN-g
stimulation.
Activation of JNK kinase activity was carried out using a
c-Jun/GST fusion protein as a exogenous substrate. JNK
activity was detectable after 1 h stimulation with LPS and
IFN-g in both wild-type and mutant PEMs and BMDMs
(Fig. 7). There was no consistent difference in JNK kinase
activation between LPS-treated wild-type and hck2/2fgr2/2
lyn2/2 macrophages. In separate experiments, both JNK
and ERK1/2 activation was observed within 15 min of
LPS stimulation in wild-type and mutant cells (data not
shown).
Effects of LPS on Activation of NF-kB DNA Binding Activ-
ity in hck2/2fgr2/2lyn2/2 Macrophages. Another major sig-
naling pathway that is initiated in macrophages after LPS
treatment is activation of NF-kB DNA binding activity by
dissociation from Ik-B (37). To assess whether the loss of
Hck, Fgr, and Lyn affected NF-kB activation after LPS
stimulation, we performed electrophoretic mobility shift
assays (EMSA) using nuclear extracts from untreated and
LPS-treated cells incubated with a double-stranded oligo-
nucleotide containing an NF-kB recognition sequence
(38). After LPS/IFN-g stimulation for 2 h, we detected in-
ducible NF-kB DNA binding activity in PEMs and BMDMs
derived from both wild-type and hck2/2fgr2/2lyn2/2 mac-
rophages (Fig. 8). No binding was observed using an oligo-
nucleotide containing point mutations in the NF-kB rec-
ognition sequence. The results demonstrate that the deficiency
of Hck, Fgr, and Lyn did not effect NF-kB activation by LPS.
Herbimycin A Inhibits MAPK Phosphorylation and Nitrite
Production in hck2/2fgr2/2lyn2/2 Macrophages. To investigate
whether  macrophage activation by LPS remained dependent
on tyrosine kinase activity in hck2/2fgr2/2lyn2/2 macrophages,
Figure 7. Analysis of ERK1/2
and JNK activation after LPS/
IFN-g stimulation. PEMs and
BMDMs from wild-type and
hck2/2fgr2/2lyn2/2 mutant mice
were stimulated with LPS (10
ng/ml) and IFN-g (20 ng/ml) for
the indicated time periods, then
total cell lysates prepared. ERK1/2
and JNK proteins were immuno-
precipitated (250 mg of cell lysates)
using ERK1/2 and JNK poly-
clonal antibodies, respectively,
and tested for kinase activity in
the presence of g-[33P]ATP us-
ing MBP and C-Jun fusion pro-
tein, respectively, as substrates.
Phosphorylated proteins were
resolved on 12% SDS-PAGE.
we examined the effects of the protein tyrosine kinase
inhibitor herbimycin A on LPS-induced tyrosine phosphor-
ylation and secretion of nitrite. As shown in Fig. 9 A, pre-
treatment with herbimycin A significantly reduced LPS-
induced tyrosine phosphorylation of the p42 (ERK1/2)
protein in both wild-type and mutant cells. Similarly, nitrite
production (Fig. 9 B) was reduced to the same extent in
both wild-type and hck2/2fgr2/2lyn2/2 BMDMs. This evi-
dence demonstrates despite the lack of Hck, Fgr, and Lyn,
the triple mutant macrophages remain sensitive to inhibi-
tion of LPS-induced activation by the protein tyrosine ki-
nase inhibitor herbimycin A.
Discussion
Exposure of macrophages to bacterial LPS initiates a sig-
nal transduction cascade that leads to increased production
of nitrite, secretion of proinflammatory cytokines, and ac-
quisition of enhanced bactericidal/tumoricidal activity, the
hallmarks of an activated macrophage. Therefore, regula-
tion of this signaling pathway is critical for controlling the
initial phases of the immune response to foreign organisms.
A number of signaling pathways have been implicated in
LPS responses in macrophages; however the most rapidly
induced signaling responses are likely to involve tyrosine
phosphorylation events. The predominant Src-family ki-
nases expressed in macrophages, Hck, Fgr, and Lyn, have
been implicated in a number of studies as being the initial
signal transducers for tyrosine phosphorylation events after
LPS stimulation (20–25). To directly test the role of these
kinases in LPS signaling in macrophages, we generated
hck2/2fgr2/2lyn2/2 triple mutant mice by intercrossing sin-
gle mutant animals, then tested LPS-induced functional re-
sponses and signaling properties in peritoneal exudate and
BMDM from these mice. Much to our surprise, both triple
mutant macrophage types showed no significant impair-
ments in nitrite secretion, cytokine production, tumoricidal
activation, or signal transduction after treatment with LPS.
These data conclusively demonstrate that these Src-family1667 Meng and Lowell
kinases are not required for LPS-induced signal transduc-
tion or macrophage activation.
The primary surface receptor for LPS is CD14, which
binds LPS with high affinity in the presence of LPS-bind-
ing protein. At low doses of LPS (,1 ng/ml) treatment of
macrophages with anti-CD14 mAb completely blocks all
LPS-induced signaling and macrophage functional activation
(8, 16). At higher doses (.10 ng/ml) of LPS, anti-CD14
mAbs do not completely block LPS signaling or functional
activation, indicating that CD14-independent mechanisms
of LPS stimulation can occur. Moreover, activation of macro-
phages derived from CD14-deficient mice has also been
observed at high LPS doses (7). The experiments done in
this work were all conducted in the low dose range of LPS,
hence the majority of signaling we examined was CD14
dependent. Since CD14 is a GPI-linked protein, and hence
has no intracellular protein domains, it has been postulated
that it serves only as a binding protein and that the LPS–
CD14 complex then associates with another transmembrane
protein that serves as the primary signal transduction unit
(39). In analogy to many cytokine receptors, this het-
erodimeric LPS receptor complex would then activate the
appropriate membrane associated tyrosine kinases to initiate
the signaling cascade. Clearly, this process occurs normally
in the absence of Hck, Fgr, and Lyn. Since triple mutant
macrophages expressed normal levels of CD14, high-affin-
ity binding of LPS is presumably not altered in the hck2/2
fgr2/2lyn2/2 cells. However, it is possible that the putative
signal transducing subunit may have specificity for a wide
range of kinases, or that CD14 can associate with a variety
of signal transducing molecules, so that other non–Src-fam-
ily kinases may be recruited to the membrane. Another
possible explanation for the normal LPS responses in hck2/2
fgr2/2lyn2/2 mutants would be compensation by other Src-
family kinases that become aberrantly expressed in the tri-
ple mutant cells; however, immunoblot analysis revealed
that no other Src-family kinases were expressed in the triple
mutant cells (Fig. 2). Src has been reported to be expressed
in human monocytes (40), however we did not detect it in
our immunoblots. Moreover, LPS-induced nitrite secretion
and cytokine production occur normally in src2/2 macro-
phages (Lowell, C.A., unpublished observations). Never-
theless, we can not rule out that very low expression of
known Src-family kinases, or the presence of other unde-
scribed Src-family kinases, may be contributing to LPS-
induced responses in our hck2/2 fgr2/2lyn2/2 macrophages.
One such kinase may be the Yrk kinase; a Src-family kinase
cloned from avian cells for which a mammalian homologue
has not yet been described (41).
Based on previous studies, macrophage activation by
LPS is closely related to activation of Src-family kinases in
macrophages, in particular Hck and Lyn, and correlates
Figure 9. Effects of herbimycin A on LPS inducible tyrosine phosphor-
ylation and nitrite secretion. (A) BMDMs from wild-type or hck2/2fgr2/2
lyn2/2 mice were cultured in the presence of herbimycin A (10 mg/ml)
for 4 h, then stimulated with LPS (10 ng/ml) and IFN-g (20 ng/ml) for
30 min. Total cell lysates were prepared and electrophoresed on 10%
SDS-PAGE, transferred to nitrocellulose and blotted with antiphosphoty-
rosine mAb 4G10. (B) BMDMs were pretreated with herbimycin A then
stimulated for 12 h with LPS/IFN-g. Nitrite release was measured using
the Greiss reagent.
Figure 8. Activation of NF-kB binding activity by LPS/IFN-g. PEM
and BMDM (5 3 106 cells/assay) from wild-type and hck2/2fgr2/2lyn2/2
mice were cultured with or without LPS (10 ng/ml) and IFN-g (20 ng/ml)
for 2 h. Nuclear extracts were prepared and incubated with a a-[32P]dCTP–
labeled double-stranded oligonucleotide, corresponding to the murine
immunoglobulin k enhancer site. Protein-bound oligonucleotides were
resolved by electrophoresis. Specific binding by NF-kB was confirmed by
using an oligonucleotide containing mutations in the NF-kB binding
motif. S, specific binding to wild-type oligonucleotide; NS, non-specific
binding to oligonucleotide containing point mutations.1668 LPS Signaling in hck2/2fgr2/2lyn2/2 Mice
with the association of Lyn with CD14 and PI3-kinase (21,
23). However, as shown in Figs. 3 and 4, a deficiency of
these kinases does not impair nitrite secretion or cytokine
release over a wide range of LPS concentrations. Indeed,
with thioglycolate-elicited PEM, we observed just the op-
posite, the triple mutant macrophages tended to be hyper-
responsive to LPS activation. The hyperresponsiveness of
hck2/2fgr2/2lyn2/2 PEMs was correlated with the observa-
tions that LPS-induced tyrosine phosphorylation of the
p42/p44 ERK proteins was slightly higher and more pro-
longed in triple mutant cells compared to wild-type (Fig.
6), although we were unable to demonstrate increased en-
zymatic activation of these kinases. Analysis of hck2/2fgr2/2
double mutants and lyn2/2 single mutant mice has shown
that the hyperresponsiveness of PEMs is the result of the
loss of Lyn activity (data not shown and reference 28). Thus,
it appears that rather than serving as a positive regulator of
LPS signaling, it is more likely that the Lyn kinase can serve
as a negative regulator of macrophage activation. A nega-
tive regulatory function of Lyn is also observed in lyn2/2
B-cells (Chan et al., manuscript submitted for publication
and reference 34). Cross-linking of the B cell antigen re-
ceptor on lyn2/2 cells produces a hyperproliferative response
that is correlated with enhanced activation of ERK1/
ERK2. The hyperresponsiveness of immune cells from lyn2/2
mice may contribute to the development of autoimmunity
in these animals (33, 35). lyn2/2 B-cells also failed to show
normal downregulation of proliferation after co–cross-link-
ing of the antigen receptor with the FcgRIIB receptor
(Chan et al., manuscript submitted for publication and 34).
The FcgRIIB receptor is known to downregulate antigen
receptor signaling by recruiting the tyrosine phosphatase,
SHP-1, into the receptor complex (42), suggesting that
Lyn may be required for activation of this tyrosine phos-
phatase. Alternatively, Lyn may be required for activation
of the p145SHIP inositol phosphatase, which has also been
implicated in downregulation B cell and mast cell activa-
tion through the FcgRIIB receptor (43). Whether Lyn is
acting to regulate these tyrosine phosphatases and whether
they, in turn, function to downregulate LPS-induced mac-
rophage activation remains to be determined. Of the cy-
tokines we tested, it appeared that hck2/2fgr2/2lyn2/2 mac-
rophages showed the greatest overproduction of IL-1.
Indeed, we found that PEMs from the triple mutant mice
spontaneously secreted IL-1 in the presence of IFN-g alone
and when cultured without any stimuli at all (Fig. 4 and
data not shown). Since IL-1 production has been shown to
induce expression of IL-6 by inflammatory macrophages
elicited with turpentine injection (44), it is possible that the
higher levels of IL-6 production may be secondary to con-
tinuous IL-1 secretion. In contrast to PEMs, triple mutant
BMDMs do not spontaneously secrete IL-1; hence some
aspect of the inflammatory stimulus caused by the perito-
neal injection of thioglycolate used to elicit macrophage in-
flux into the abdominal cavity is contributing to the hyper-
responsiveness of these cells.
Most of the experiments shown use macrophages that
are stimulated with LPS plus IFN-g. We found that PEMs
failed to respond to LPS-alone stimulation (as assessed by
nitrite and cytokine release) while BMDMs showed less ro-
bust responses. Induction of macrophage tumor cell cyto-
toxicity also requires costimulation of cells with LPS plus
IFN-g (31). The mechanism by which IFN-g primes mac-
rophages for augmented responses to LPS is unknown,
however it is unlikely to be mediated by increased signaling
through Src-family kinases since the triple mutant BMDMs
showed equivalent enhancement of LPS responses with
IFN-g costimulation compared to wild-type cells.
The induction of tumor cell cytotoxicity in hck2/2fgr2/2
lyn2/2 macrophages by LPS/IFN-g was completely normal
in BMDMs but reproducibly showed a 50% decrease in
PEMs (Fig. 5). Given that other aspects of macrophage ac-
tivation and signal transduction caused by LPS were in-
creased in triple mutant PEMs, the cause for the modest
impairment in tumoricidal capability is unclear. Previous
work has suggested that hck2/2fgr2/2 neutrophils and macro-
phages have defects related to integrin-mediated adhesion
(45). Since integrin-dependent adhesion also contributes to
macrophage cytotoxicity (46), it is possible that impair-
ments in cell adhesion may account for the slightly dimin-
ished tumoricidal capacity of triple mutant PEMs.
Activation of the pleiotropic transcription factor NF-kB
is also a well-described signaling pathway initiated by LPS
treatment of macrophages (10). Activation of NF-kB DNA
binding activity requires phosphorylation of serine residues
of both the p65 and p50 subunits (47). Although the signal-
ing pathway from membrane CD14 that leads to NF-kB
activation is not clearly defined, tyrosine phosphorylation
events may be important, since herbimycin A will block
LPS-induced NF-kB activation (48). An indirect effect of
herbimycin A on inhibition of NF-kB activation has also
been suggested (49). Activation of NF-kB binding activity
occurred normally in LPS/IFN-g–stimulated triple mutant
macrophages (Fig. 8), demonstrating that these Src-family
kinases are not essential in initiating this LPS-induced signal
transduction pathway.
The major conclusion from this work is that despite the
biochemical evidence suggesting that Hck, Fgr, and Lyn
are involved in LPS signal transduction, macrophages that
are devoid of these kinases, and express no other detectable
Src-family kinases, have normal (or even enhanced) LPS
functional responses. Activation of the major mediators of
LPS signal transduction—MAP kinases, JNK, and NF-
kB—occurs essentially normally in the absence of Src-fam-
ily kinases. This begs the question of what is (are) the other
kinase(s) responsible for in CD14-mediated LPS signal
transduction. Based on the observation that herbimycin A
suppresses nitrite production and p42/44 activation equiva-
lently in both wild-type and triple mutant macrophages
(Fig. 9 A), a tyrosine kinase is likely to be involved in some
step of the pathway, though not necessarily at the initial
step. It is unlikely that the p72syk kinase is involved, since
LPS responses are also normal in syk2/2 mutant macrophages
(Crowley, M., and A. DeFranco, unpublished observa-
tions). An attractive candidate for the kinase responsible for
initiating LPS signaling may be the ceramide activated pro-1669 Meng and Lowell
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